Bill Gates-backed Oxford biotech totals $100M funding to discover new drugs using AI
Oxford-based Exscientia is a clinical-stage pharmatech that uses Artificial Intelligence (AI) to design and discover new drugs. The company just announced that BlackRock’s funds joined...